Garrison Point Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.98M Sell
5,460
-220
-4% -$75.3K 0.8% 32
2026
Q1
$2M Sell
5,680
-50
-0.9% -$17.8K 0.91% 27
2025
Q4
$1.88M Sell
5,730
-98
-2% -$31.1K 0.83% 29
2025
Q3
$1.64M Sell
5,828
-108
-2% -$31.3K 0.69% 35
2025
Q2
$1.66M Sell
5,936
-260
-4% -$73.7K 0.76% 35
2025
Q1
$1.93M Sell
6,196
-307
-5% -$90.7K 0.94% 26
2024
Q4
$1.69M Hold
6,503
0.8% 34
2024
Q3
$2.1M Sell
6,503
-10
-0.2% -$3.27K 1.3% 17
2024
Q2
$2.03M Sell
6,513
-495
-7% -$145K 1.34% 17
2024
Q1
$1.99M Hold
7,008
1.28% 17
2023
Q4
$2.02M Sell
7,008
-100
-1% -$27.2K 1.42% 14
2023
Q3
$1.91M Buy
7,108
+48
+0.7% +$12K 1.48% 15
2023
Q2
$1.57M Sell
7,060
-35
-0.5% -$8.12K 1.13% 22
2023
Q1
$1.72M Sell
7,095
-60
-0.8% -$14.7K 1.29% 20
2022
Q4
$1.88M Sell
7,155
-110
-2% -$29.5K 1.54% 16
2022
Q3
$1.64M Buy
7,265
+20
+0.3% +$4.85K 1.46% 17
2022
Q2
$1.76M Hold
7,245
1.46% 17
2022
Q1
$1.75M Hold
7,245
1.23% 23
2021
Q4
$1.63M Hold
7,245
1.08% 26
2021
Q3
$1.54M Hold
7,245
1.12% 27
2021
Q2
$1.77M Sell
7,245
-5
-0.1% -$1.23K 1.27% 23
2021
Q1
$1.8M Hold
7,250
1.4% 19
2020
Q4
$1.67M Hold
7,250
1.34% 22
2020
Q3
$1.84M Hold
7,250
1.67% 13
2020
Q2
$1.71M Sell
7,250
-285
-4% -$65K 1.69% 14
2020
Q1
$1.53M Sell
7,535
-170
-2% -$37.1K 1.87% 10
2019
Q4
$1.86M Hold
7,705
1.7% 10
2019
Q3
$1.49M Buy
7,705
+10
+0.1% +$1.92K 1.48% 18
2019
Q2
$1.42M Sell
7,695
-461
-6% -$82.5K 1.42% 25
2019
Q1
$1.55M Buy
8,156
+136
+2% +$26K 1.61% 15
2018
Q4
$1.56M Buy
+8,020
New +$1.56M 1.93% 9

Other funds holding AMGN

Garrison Point Advisors's AMGN Position: Q2 2026 in Review

Garrison Point Advisors reduced its Amgen (AMGN) stake by 3.9% in Q2 2026, selling an estimated $75.3K and leaving 5,460 shares worth $1.98M. The position accounts for 0.8% of the portfolio, ranked #32.

Garrison Point Advisors first reported a position in AMGN in Q4 2018 and has held it in 31 quarters since. The position peaked at $2.1M in Q3 2024. 1,543 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Garrison Point Advisors held 5,460 shares of Amgen worth $1.98M as of Q2 2026.
  • Garrison Point Advisors sold 220 Amgen shares in Q2 2026, an estimated $75.3K.
  • Amgen made up 0.8% of Garrison Point Advisors's portfolio in Q2 2026, its #32 holding.
  • Garrison Point Advisors first reported a position in Amgen in Q4 2018 and has held it in 31 quarters since.
  • Garrison Point Advisors's Amgen position peaked at $2.1M in Q3 2024.
  • 1,543 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Garrison Point Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.